Skip to content
HomeLatest newsCaring for the planet like our health depends on it: Johnson & Johnson partners with the C40 Cities Climate Leadership Group
C40 Summit: Mexico City gradient overlay

Caring for the planet like our health depends on it: Johnson & Johnson partners with the C40 Cities Climate Leadership Group

The company has committed $1 million to help 90 cities around the globe improve air quality—and human health.

Share Article
share to

It was a clear fall day, and I was driving along Interstate 95 with my then-5-year-old son in the back seat. We were passing a particularly industrial stretch of the highway when he asked if what he saw coming out of the smokestacks made God cough.

The truth was that the smoke was steam, but I marveled at the connection my son had just made between the health of people and the health of the planet. I answered, “It might rabbit, it might.”

The World Health Organization (WHO) has declared climate change to be one of the greatest threats to global health in the 21st century. The organization estimates that one in four premature deaths worldwide are caused by environmental factors, and 3 million deaths each year are linked to exposure to air pollution.

Connecting the dots between human and environmental health

As a company that began its formal energy program more than 30 years ago, Johnson & Johnson has long understood that the health of people depends on the health of the planet.

That’s why we are thrilled to announce our support for the C40 Cities Climate Leadership Group—a network of the world’s 90 megacities that want to help improve the health of the globe—with a commitment of $1 million over two years to help fund programs that will link climate action with the benefits to air quality and human health.

Together with C40, we aim to drive positive climate programs on a grand scale, helping to deliver 14,000 actions over the next four years—actions that the C40 Deadline 2020 report says are necessary to help meet the Paris Agreement commitments.

Positive change at the scale we need is a team effort, requiring people, companies and governments to work together to care for the planet like our health depends on it.

And we believe that connecting human health, air quality and climate change will unlock mainstream behavior and policy change at the pace and scale we need.

So why the focus on cities? For the first time in history, more than half the world’s population now lives in metropolitan areas—and that number is expected to rise to nearly 70% by 2050.

And according to the WHO, more than 80% of urban residents are exposed to unsafe air, a number that rises to 98% in low- and middle-income countries. Cities are also estimated to contribute more than 70% of greenhouse gas emissions, making them the perfect nexus for climate actions that can improve air quality and human health outcomes at scale.

At Johnson & Johnson, we’ve been building the case for positive climate action for decades.

The actions that we have taken have reduced our greenhouse gas emissions and energy costs by about 20% over the past 10 years. We have also increased our use of renewable electricity to nearly 25% by building renewable energy systems on our properties globally, and buying wind power in the U.S.

As the world’s largest, most broadly-based healthcare company, we also understand that we can share our voice and experience to create change beyond our four walls. C40 represents more than 650 million people and one-quarter of the global economy.

This partnership will put us firmly on the front lines of a collaborative effort that has the potential to drastically improve the trajectory of climate change and human health.

Positive change at the scale we need is a team effort, requiring people, companies and governments to work together to care for the planet like our health depends on it. Because, frankly, it does.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.